ASMS 2017 – Life science researchers can gain greater insights from their metabolomic and proteomic data and be more productive by using new software and cloud-based solutions from Thermo Fisher...

ASMS 2017 – Scientists studying complex protein samples can now take advantage of a new high-performing Orbitrap mass spectrometer designed to quickly and consistently produce superior data...

Boehringer Ingelheim today announced that Phase II results from LUME-Meso, a randomized, double-blind, placebo-controlled trial, have been presented as part of an Oral Abstract Session at the 2017...

ASMS 2017 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, strengthened its leadership in mass spectrometry by launching new technologies to advance cutting-edge...

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced new Phase 1...